FUTURE 3 Study Extension

Mise à jour : Il y a 4 ans
Référence : NCT01338415

Femme et Homme

Extrait

The objectives of the FUTURE 3 Study Extension are to evaluate the long-term safety, tolerability and efficacy of the pediatric formulation of bosentan two versus three times a day in children with Pulmonary Arterial Hypertension (PAH).


Critère d'inclusion

  • pulmonary arterial hypertension


Liens